VolitionRx Limited Soared
Tue, Apr 23, 2024 at 07:10 PM
VolitionRx Limited (VNRX:NYSEMKT) jumped higher at $0.85, representing a gain of 41.7%. On Tue, Apr 23, 2024, VNRX:NYSEMKT touched a New 2-Week High of $0.85. The stock appeared on our News Catalysts scanner on Tue, Apr 23, 2024 at 09:32 AM in the 'BIOTECH' category. From Tue, Apr 09, 2024, the stock recorded 20.00% Up Days and 36.36% Green Days
About VolitionRx Limited (VNRX:NYSEMKT)
VolitionRX Ltd is a clinical-stage life sciences company. The Company is engaged in developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases.
Top 10 Gainers:
- Cazoo Group Ltd Class A (CZOO:NYSE), 80.76%
- NewGenIvf Group Limited (NIVF:NASDAQ), 74.22%
- Arrowroot Acquisition Corp. (ARRW:NASDAQ), 54.64%
- Mmtec, Inc. (MTC:NASDAQ), 42.68%
- VolitionRx Limited (VNRX:NYSEMKT), 41.67%
- Oportun Financial Corporation (OPRT:NASDAQ), 40%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 38.89%
- Shimmick Corporation (SHIM:NASDAQ), 35.33%
- Movella Holdings Inc Com (MVLA:NASDAQ), 30.43%
- Hitek Global Inc. (HKIT:NASDAQ), 30.39%